Skip to content
中文产业新闻精选评分69Chinese source

FDA批准泽尼达妥单抗联合替雷利珠单抗及化疗用于HER2阳性胃食管腺癌一线治疗

美国FDA批准HER2双抗泽尼达妥单抗联合百济PD-1用于胃癌等一线治疗 附原始幻灯

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.